Interleukin-4 enhances trafficking and functional activities of GM-CSF-stimulated mouse myeloid-derived dendritic cells at late differentiation stage

Experimental Cell Research

Volumn 317, Issue 15, 2011, Pages 2210-2221

  Yin, Shu Yi ^a,b,c   Wang, Chien Yu ^a   Yang, Ning Sun ^a,b,c  

^a AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c ACADEMIA SINICA   (Taiwan)

Author keywords

Bone marrow derived dendritic cells; Interleukin 4; Temporal control; Trafficking

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CULTURE MEDIUM; CYTOKINE RELEASE; FEMALE; LYMPHOCYTE PROLIFERATION; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

EID: 79960847915     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.06.013     Document Type: Article

References (56)

1. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
2. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 1991, 9:271-296.
3. Davis I.D., Jefford M., Parente P., Cebon J. Rational approaches to human cancer immunotherapy. J. Leukoc. Biol. 2003, 73:3-29.
4. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
5. Banchereau J., Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 2005, 5:296-306.
6. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992, 176:1693-1702.
7. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994, 179:1109-1118.
8. Labeur M.S., Roters B., Pers B., Mehling A., Luger T.A., Schwarz T., Grabbe S. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J. Immunol. 1999, 162:168-175.
9. Jonuleit H., Giesecke-Tuettenberg A., Tuting T., Thurner-Schuler B., Stuge T.B., Paragnik L., Kandemir A., Lee P.P., Schuler G., Knop J., Enk A.H. A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int. J. Cancer 2001, 93:243-251.
10. Schuler-Thurner B., Schultz E.S., Berger T.G., Weinlich G., Ebner S., Woerl P., Bender A., Feuerstein B., Fritsch P.O., Romani N., Schuler G. Rapid induction of tumor-specific type 1T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J. Exp. Med. 2002, 195:1279-1288.
11. Randolph G.J., Ochando J., Partida-Sanchez S. Migration of dendritic cell subsets and their precursors. Annu. Rev. Immunol. 2008, 26:293-316.
12. Sozzani S., Allavena P., Vecchi A., Mantovani A. The role of chemokines in the regulation of dendritic cell trafficking. J. Leukoc. Biol. 1999, 66:1-9.
13. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Ait-Yahia S., Briere F., Zlotnik A., Lebecque S., Caux C. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 1998, 188:373-386.
14. Tanaka H., Demeure C.E., Rubio M., Delespesse G., Sarfati M. Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors. Role of stimulator/responder ratio. J. Exp. Med. 2000, 192:405-412.
15. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 1999, 223:77-92.
16. Brasel K., De Smedt T., Smith J.L., Maliszewski C.R. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 2000, 96:3029-3039.
17. Son Y.I., Egawa S., Tatsumi T., Redlinger R.E., Kalinski P., Kanto T. A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells. J. Immunol. Methods 2002, 262:145-157.
18. Lehtonen A., Veckman V., Nikula T., Lahesmaa R., Kinnunen L., Matikainen S., Julkunen I. Differential expression of IFN regulatory factor 4 gene in human monocyte-derived dendritic cells and macrophages. J. Immunol. 2005, 175:6570-6579.
19. Jackson S.H., Yu C.R., Mahdi R.M., Ebong S., Egwuagu C.E. Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling. J. Immunol. 2004, 172:2307-2315.
20. Garrigan K., Moroni-Rawson P., McMurray C., Hermans I., Abernethy N., Watson J., Ronchese F. Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors. Blood 1996, 88:3508-3512.
21. Lutz M.B., Rovere P., Kleijmeer M.J., Rescigno M., Assmann C.U., Oorschot V.M., Geuze H.J., Trucy J., Demandolx D., Davoust J., Ricciardi-Castagnoli P. Intracellular routes and selective retention of antigens in mildly acidic cathepsin D/lysosome-associated membrane protein-1/MHC class II-positive vesicles in immature dendritic cells. J. Immunol. 1997, 159:3707-3716.
22. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998, 8:275-283.
23. Weaver D.J., Poligone B., Bui T., Abdel-Motal U.M., Baldwin A.S., Tisch R. Dendritic cells from nonobese diabetic mice exhibit a defect in NF-kappa B regulation due to a hyperactive I kappa B kinase. J. Immunol. 2001, 167:1461-1468.
24. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002, 2:151-161.
25. de Jong E.C., Smits H.H., Kapsenberg M.L. Dendritic cell-mediated T cell polarization. Springer Semin. Immunopathol. 2005, 26:289-307.
26. Gilliet M., Boonstra A., Paturel C., Antonenko S., Xu X.L., Trinchieri G., O'Garra A., Liu Y.J. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 2002, 195:953-958.
27. Feili-Hariri M., Falkner D.H., Morel P.A. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy. J. Leukoc. Biol. 2005, 78:656-664.
28. Ansel K.M., Djuretic I., Tanasa B., Rao A. Regulation of Th2 differentiation and Il4 locus accessibility. Annu. Rev. Immunol. 2006, 24:607-656.
29. N. Dawson, Immunotherapeutic approaches in prostate cancer: PROVENGE, Clin. Adv. Hematol. Oncol. 8 419-421.
30. Rosenberg S.A., Yang J.C., Restifo N.P. Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 2004, 10:909-915.
31. Schook L.B., Gutmann D.H., Marlin L.E., Niederhuber J.E. In-vitro-derived bone marrow macrophages. Expression of Ia antigens during macrophage differentiation. Transplantation 1984, 37:585-590.
32. Armstrong J.W., Simske S.J., Beharka A.A., Balch S., Luttges M.W., Chapes S.K. Class I and class II major histocompatibility molecules play a role in bone marrow-derived macrophage development. J. Leukoc. Biol. 1994, 55:658-661.
33. Z. Zhou, D.L. French, G. Ma, S. Eisenstein, Y. Chen, C.M. Divino, G. Keller, S.H. Chen, P.Y. Pan, Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells, Stem Cells 28 620-632.
34. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009, 9:162-174.
35. Garcia-Ojeda M.E., Dejbakhsh-Jones S., Weissman I.L., Strober S. An alternate pathway for T cell development supported by the bone marrow microenvironment: recapitulation of thymic maturation. J. Exp. Med. 1998, 187:1813-1823.
36. Dejbakhsh-Jones S., Strober S. Identification of an early T cell progenitor for a pathway of T cell maturation in the bone marrow. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:14493-14498.
37. Marhaba R., Vitacolonna M., Hildebrand D., Baniyash M., Freyschmidt-Paul P., Zoller M. The importance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczema. J. Immunol. 2007, 179:5071-5081.
38. Ushio-Umeda Y., Yoshida R. Mechanisms of allografted tumor rejection: the roles of T cells in allograft rejection mediated by a type of bone marrow-derived macrophage. Microbiol. Immunol. 1997, 41:981-990.
39. Schuetz F., Ehlert K., Ge Y., Schneeweiss A., Rom J., Inzkirweli N., Sohn C., Schirrmacher V., Beckhove P. Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study. Cancer Immunol. Immunother. 2009, 58:887-900.
40. Bruno L., Seidl T., Lanzavecchia A. Mouse pre-immunocytes as non-proliferating multipotent precursors of macrophages, interferon-producing cells, CD8alpha(+) and CD8alpha(-) dendritic cells. Eur. J. Immunol. 2001, 31:3403-3412.
41. Kondo M., Weissman I.L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997, 91:661-672.
42. Akashi K., Traver D., Miyamoto T., Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000, 404:193-197.
43. Manz M.G., Traver D., Miyamoto T., Weissman I.L., Akashi K. Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood 2001, 97:3333-3341.
44. Traver D., Akashi K., Manz M., Merad M., Miyamoto T., Engleman E.G., Weissman I.L. Development of CD8alpha-positive dendritic cells from a common myeloid progenitor. Science 2000, 290:2152-2154.
45. del Hoyo G.M., Martin P., Vargas H.H., Ruiz S., Arias C.F., Ardavin C. Characterization of a common precursor population for dendritic cells. Nature 2002, 415:1043-1047.
46. Corcoran L., Ferrero I., Vremec D., Lucas K., Waithman J., O'Keeffe M., Wu L., Wilson A., Shortman K. The lymphoid past of mouse plasmacytoid cells and thymic dendritic cells. J. Immunol. 2003, 170:4926-4932.
47. Heufler C., Koch F., Stanzl U., Topar G., Wysocka M., Trinchieri G., Enk A., Steinman R.M., Romani N., Schuler G. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur. J. Immunol. 1996, 26:659-668.
48. Lutz M.B., Suri R.M., Niimi M., Ogilvie A.L., Kukutsch N.A., Rossner S., Schuler G., Austyn J.M. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur. J. Immunol. 2000, 30:1813-1822.
49. Lutz M.B., Schnare M., Menges M., Rossner S., Rollinghoff M., Schuler G., Gessner A. Differential functions of IL-4 receptor types I and II for dendritic cell maturation and IL-12 production and their dependency on GM-CSF. J. Immunol. 2002, 169:3574-3580.
50. Hochrein H., O'Keeffe M., Luft T., Vandenabeele S., Grumont R.J., Maraskovsky E., Shortman K. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J. Exp. Med. 2000, 192:823-833.
51. Maroof A., Penny M., Kingston R., Murray C., Islam S., Bedford P.A., Knight S.C. Interleukin-4 can induce interleukin-4 production in dendritic cells. Immunology 2006, 117:271-279.
52. Stacker S.A., Springer T.A. Leukocyte integrin P150,95 (CD11c/CD18) functions as an adhesion molecule binding to a counter-receptor on stimulated endothelium. J. Immunol. 1991, 146:648-655.
53. Harding C.V., Unanue E.R. Cellular mechanisms of antigen processing and the function of class I and II major histocompatibility complex molecules. Cell Regul. 1990, 1:499-509.
54. Bernhard H., Disis M.L., Heimfeld S., Hand S., Gralow J.R., Cheever M.A. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res. 1995, 55:1099-1104.
55. Rosenzwajg M., Camus S., Guigon M., Gluckman J.C. The influence of interleukin (IL)-4, IL-13, and Flt3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells. Exp. Hematol. 1998, 26:63-72.
56. Senju S., Suemori H., Zembutsu H., Uemura Y., Hirata S., Fukuma D., Matsuyoshi H., Shimomura M., Haruta M., Fukushima S., Matsunaga Y., Katagiri T., Nakamura Y., Furuya M., Nakatsuji N., Nishimura Y. Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory function. Stem Cells 2007, 25:2720-2729.